Maiyar A C, Phu P T, Huang A J, Firestone G L
Department of Molecular and Cell Biology, University of California at Berkeley 94720, USA.
Mol Endocrinol. 1997 Mar;11(3):312-29. doi: 10.1210/mend.11.3.9893.
sgk is a novel member of the serine/threonine protein kinase family that is transcriptionally regulated by serum and glucocorticoids in Rat2 fibroblasts and in mammary epithelial cells. 5'-Deletion analysis of the sgk promoter, using a series of sgk-CAT. (chloramphenicol acetyltransferase) chimeric reporter gene plasmids, defined a glucocorticoid-responsive region that contains a glucocorticoid response element (sgkGRE) between -1000 and -975 bp. The sgkGRE is specifically bound by glucocorticoid receptors and is sufficient to confer glucocorticoid responsiveness to a heterologous promoter in several cell lines. Strikingly, cotransfection of either the murine or human wild type p53, but not a mutant p53, repressed the dexamethasone-stimulated transactivation of reporter plasmids containing either the sgkGRE or a consensus GRE. Gel shift analysis revealed that in vitro synthesized p53 prevented binding of the glucocorticoid receptor both to the sgkGRE as well as to a consensus GRE. The p53-mediated repression of dexamethasone-induced sgkGRE activity required both the DNA binding and transactivation functions of the p53 protein. Activation of endogenous p53, by exposure to UV light, repressed the glucocorticoid receptor transactivation of a consensus GRE-CAT reporter plasmid in transfected cells. Conversely, activated glucocorticoid receptors suppressed the transactivation function of p53, while transrepression by p53 was largely unaffected. The presented data demonstrate that sgk is a primary glucocorticoid-responsive protein kinase gene that implicates a new pathway of cross-talk between steroid receptor signaling and cellular phosphorylation cascades. In addition, our study provides the first evidence of mutual interference of transactivation functions of p53 and the glucocorticoid receptor, possibly through their direct interaction.
sgk是丝氨酸/苏氨酸蛋白激酶家族的一个新成员,在大鼠2成纤维细胞和乳腺上皮细胞中受血清和糖皮质激素转录调控。使用一系列sgk - CAT(氯霉素乙酰转移酶)嵌合报告基因质粒对sgk启动子进行5' - 缺失分析,确定了一个糖皮质激素反应区域,该区域在 - 1000至 - 975 bp之间包含一个糖皮质激素反应元件(sgkGRE)。sgkGRE能被糖皮质激素受体特异性结合,并且足以在几种细胞系中赋予异源启动子糖皮质激素反应性。引人注目的是,共转染小鼠或人类野生型p53而非突变型p53,可抑制含有sgkGRE或共有GRE的报告质粒的地塞米松刺激的反式激活。凝胶迁移分析表明,体外合成的p53可阻止糖皮质激素受体与sgkGRE以及共有GRE的结合。p53介导的对地塞米松诱导的sgkGRE活性的抑制需要p53蛋白的DNA结合和反式激活功能。通过暴露于紫外线下激活内源性p53,可抑制转染细胞中共有的GRE - CAT报告质粒的糖皮质激素受体反式激活。相反,激活的糖皮质激素受体抑制p53的反式激活功能,而p53的反式抑制在很大程度上不受影响。所呈现的数据表明,sgk是一种主要的糖皮质激素反应性蛋白激酶基因,这暗示了类固醇受体信号传导与细胞磷酸化级联反应之间新的相互作用途径。此外,我们的研究首次提供了p53和糖皮质激素受体反式激活功能相互干扰的证据,可能是通过它们的直接相互作用。